← Open Payments lookup

KYLE BARTSCHMID: Open Payments

NPI 1528460276 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$798 in 35 payments from 9 companies in 2025. Trend: 2023 $405 · 2024 $307 · 2025 $798

Food & beverage: $658Education: $140
CompanyPaymentsAmount
Regeneron Healthcare Solutions, Inc.13$293
GENZYME CORPORATION8$184
Optinose US, Inc.3$69
AstraZeneca Pharmaceuticals LP3$65
Novartis Pharmaceuticals Corporation2$48
ARS Pharmaceuticals Operations, Inc.2$47
Amgen Inc.1$34
GlaxoSmithKline, LLC.2$34
Organon LLC1$23

Products named: DUPIXENT, Xhance, NEFFY, TEZSPIRE, Rhapsido, TRELEGY ELLIPTA, AIRSUPRA, NUCALA.

Industry payments across TX — which companies pay providers there.